Tropomyosin synthesis accompanies formation of actin filaments in embryonal carcinoma cells induced to differentiate by hexamethylene bisacetamide.
Hexamethylene bisacetamide (HMBA) induces in vitro the cytodifferentiation of PCC3/A/1 mouse embryonal carcinoma (EC) cells. In EC cells, actin is associated with surface structures but microfilament bundles are not seen. After 2 days of HMBA treatment, rounded EC cells are converted to flat adhesive ones with a developed cytoskeleton containing actin and tropomyosin. The ratio of actin to total proteins is constant in EC cells and their HMBA derivatives; but a striking difference is observed for one of the newly synthesized proteins (Mr 34,000) identified as tropomyosin. Synthesis of tropomyosin is followed by its association with actin microfilament bundles, as revealed by indirect immunofluorescence microscopy with specific antibodies.
D000081:Acetamides / Q000494:pharmacology*; D000199:Actins / Q000096:biosynthesis*; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects*; D002460:Cell Line; D003959:Diamines / Q000494:pharmacology*; D005455:Fluorescent Antibody Technique; D008715:Methionine / Q000378:metabolism; D051379:Mice; D014176:Protein Biosynthesis; D013724:Teratoma; D014335:Tropomyosin / Q000096:biosynthesis*
D000081:Acetamides; D000199:Actins; D003959:Diamines; D014335:Tropomyosin; D008715:Methionine